Shanghai Bio-heart Biological Technology Co., Ltd.
Status: Publicly traded
Direct answer
Shanghai Bio-heart Biological Technology Co., Ltd. is publicly traded on HKSE under the ticker 2185.HK.
Based in the People's Republic of China, Shanghai Bio-heart Biological Technology Co., Ltd. is a medical technology firm specializing in interventional cardiovascular devices. Its core business revolves around delivering bioresorbable scaffolds (BRS) and renal denervation (RDN) therapies to address conditions like coronary artery diseases and persistent, uncontrolled high blood pressure. The company's product...
Can you invest in Shanghai Bio-heart Biological Technology Co., Ltd.?
Yes. Shanghai Bio-heart Biological Technology Co., Ltd. trades publicly on HKSE as 2185.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai Bio-heart Biological Technology Co., Ltd.
Detailed equity research is provided by MarketSnap.